Terns Pharmaceuticals Inc (TERN) Q1 2024 Earnings: Misses Analyst Net Loss Projections

GuruFocus Research

13 May 2024 at 9:32 am·3-min read

Net Loss: Reported a net loss of $22.4 million for Q1 2024, which was better than the estimated net loss of $24.83 million.
Research and Development Expenses: R&D expenses increased to $18.6 million in Q1 2024 from $17.1 million in Q1 2023.
General and Administrative Expenses: G&A expenses slightly decreased to $6.9 million in Q1 2024 from $7.1 million in the same quarter the previous year.
Cash Position: Cash, cash equivalents, and marketable securities stood at $240.7 million as of March 31, 2024, down from $263.4 million at the end of 2023.
Earnings Per Share: Net loss per share was $0.30 for Q1 2024, compared to $0.31 for Q1 2023.
Corporate Developments: Announced key executive appointments and anticipates sufficient funds to support operations into 2026.
Future Outlook: Expects to report significant trial data from lead programs TERN-701 and TERN-601 in the second half of 2024.

Warning! GuruFocus has detected 2 Warning Sign with TERN.

On May 13, 2024, Terns Pharmaceuticals Inc (NASDAQ:TERN) disclosed its financial outcomes for the first quarter ended March 31, 2024, through an 8-K filing. The company, a clinical-stage biopharmaceutical entity, is at the forefront of developing innovative small-molecule therapies aimed at treating serious diseases like oncology and obesity.

Financial Highlights and Performance Analysis

Terns Pharmaceuticals reported a net loss of $22.4 million for Q1 2024, which is a slight increase compared to the net loss of $21.5 million in Q1 2023. This net loss translates to a per-share loss of $0.30, which is an improvement from the $0.31 loss per share in the previous year. This performance narrowly missed analyst estimates, which had anticipated a net loss of $24.83 million, or $0.34 per share.

The company's research and development (R&D) expenses rose to $18.6 million from $17.1 million year-over-year, reflecting its ongoing investment in advancing its clinical programs. General and administrative (G&A) expenses slightly decreased to $6.9 million from $7.1 million. Despite these fluctuations, the overall cash, cash equivalents, and marketable securities stood at $240.7 million, a decrease from $263.4 million at the end of December 2023. However, Terns expects these funds to sustain its planned operations into 2026.

Strategic Developments and Future Outlook

Amidst financial reporting, Terns Pharmaceuticals also highlighted significant advancements in its drug development pipeline. Key updates include ongoing Phase 1 trials for TERN-701 and TERN-601, targeting chronic myeloid leukemia (CML) and obesity, respectively. Notably, the FDA granted Orphan Drug Designation to TERN-701 for CML treatment in March 2024, potentially accelerating its development pathway.

The company eagerly anticipates interim and top-line data from these trials expected in the second half of 2024. Additionally, Terns is exploring the therapeutic potential of TERN-501 for metabolic diseases and continues its discovery efforts on TERN-800 series for obesity treatment.

Corporate Leadership Updates

In terms of corporate governance, April 2024 saw the appointment of Melita Sun Jung as Chief Business Officer. May 2024 marked another significant change with the announcement of Scott Harris as the new Chief Development Officer, succeeding Erin Quirk, M.D., who will be departing from her role as President, Head of Research and Development.

Conclusion

While Terns Pharmaceuticals Inc (NASDAQ:TERN) reported a slightly higher net loss than the previous year, it remains well-capitalized to pursue its strategic objectives. The company's robust pipeline and strategic leadership adjustments position it to potentially deliver long-term value to stakeholders, pending the successful progression of its clinical trials and regulatory achievements.

For detailed financial tables and further information about Terns Pharmaceuticals' strategic initiatives and upcoming milestones, interested parties are encouraged to view the full 8-K filing.

Explore the complete 8-K earnings release (here) from Terns Pharmaceuticals Inc for further details.

This article first appeared on GuruFocus.

The Smart Investor
4 Singapore REITs to Look Out for in June
Here are four Singapore REITs you should keep your eye on in June. The post 4 Singapore REITs to Look Out for in June appeared first on The Smart Investor.
The Smart Investor
SATS’ Profit Leaps 10-Fold for 2H FY2024, Resumes Paying Dividends: 5 Highlights from the Ground Handler’s Latest Earnings
The airline food caterer enjoyed a surge in revenue with the consolidation of WFS. The post SATS’ Profit Leaps 10-Fold for 2H FY2024, Resumes Paying Dividends: 5 Highlights from the Ground Handler’s Latest Earnings appeared first on The Smart Investor.
Insider Monkey
The Richest Country in the World by GDP
We recently compiled a list of the 50 Richest Countries in the World by GDP and in this article we will talk about the country with the largest GDP in the world. Global Economic Outlook of Richest Countries The global economy has been facing strong headwinds since the COVID-19 pandemic including the world’s richest countries […]
Yahoo Finance
Fed's stance of higher for longer likely not shaken by new inflation reading
The Fed's stance of holding interest rates higher for longer likely won't be shaken following a fresh reading from the central bank's favored inflation gauge.
Zacks
The Cheapest AI Stocks to Buy Now
All stocks have pullbacks and the AI stocks will too. Which should value investors keep on their watch lists?
Zacks
3 Stocks to Buy for Big Growth
Growth-focused investors have been rewarded considerably over the last year amid the market's remarkable run, enjoying significant gains.
Simply Wall St.
SGX Dividend Stocks To Watch In May 2024
As global markets navigate through various economic challenges, the Singapore market remains a focal point for investors looking for stable returns, particularly through dividend stocks. In light of current market conditions, selecting stocks with robust dividend yields and strong fundamentals is crucial for those looking to enhance their investment portfolios in May 2024.
Insider Monkey
Is DraftKings Inc. (NASDAQ:DKNG) the Best Up and Coming Online Betting Stock?
We recently compiled a list of the 12 Best Up and Coming Stocks To Buy According to Hedge Funds and in this article, we discuss whether DraftKings Inc. (NASDAQ:DKNG) is the best up-and-coming online gambling stock to buy now. Despite the concerns surrounding the market over the last few years, the broader market has performed […]
Yahoo Finance Video
April PCE data is 'pretty meaningful step down' for inflation
Treasury yields (^TYX, ^TNX, ^FVX) are on the decline this morning after inflation data from the PCE (Personal Consumption Expenditures) Index came in line with expectations with April's core PCE rising 0.2% month-over-month and 2.8% year-over-year. As inflation slows but price pressures remain a big risk, what does this print mean for the bond market? JPMorgan US CIO for Fixed Income, Currencies, and Commodities Kay Herr sits down in-studio with Yahoo Finance's Catalysts to look deeper into April's inflation data and what this means for the Federal Reserve's inflation rate target. "If you look underneath in some of the details, if you look on a three-month annualized basis, we've gone from a 4.4% number in March down to 3.46% in April. That's a pretty meaningful step down," Herr explains. "If you look on a month-over-month [basis], in April that was running 0.33%, March we're running 0.249%. And then on an average monthly basis in the first quarter, things were at about 0.36%, for April [it's] 0.25%. So a reasonable step down moving in line with what the Fed thinks." Herr underlines the Fed's dual mandate objective in regulators' decision on cutting interest rates or holding them higher for longer: "We're going to start to see a little bit of softness in in the labor market. And that's going to lead the Fed... to move toward cutting rates, yes."For more expert insight and the latest market action, click here to watch this full episode of Catalysts. This post was written by Luke Carberry Mogan.
Yahoo Finance
Stock market today: Stocks cap another winning month, S&P 500 logs best May since 2003
Investors waited for the release of the Fed's preferred inflation data, seen as a potential turning point for a market gripped by rate-cut jitters.
GOBankingRates
I’m an Average Middle-Class Retiree: Here’s How Much Savings I Have
Though your pre-retirement income alone isn't enough to determine whether you'll retire comfortably, it certainly plays a role. For example, if you're earning a middle-class salary, the amount you can...
Zacks
Investing in Gold: 3 Top Ranked Mining Stock to Buy Now
The price of gold has outperformed stocks this year and since 2022. The mining stocks Barrick Gold, Agnico Eagle Mines and Harmony Gold are huge beneficiaries of this rally.
Reuters
Yen weakness persists despite Tokyo's $62 billion intervention
TOKYO (Reuters) -Japanese authorities spent 9.79 trillion yen ($62.23 billion)intervening in the foreign exchange market to support the yen over the past month, in moves that kept the currency from testing new lows but are unlikely to reverse longer-term declines. The Ministry of Finance data released on Friday confirmed the suspicions of traders and analysts that Tokyo entered the market in two rounds of massive dollar-selling intervention shortly after the yen hit a 34-year low of 160.245 per dollar on April 29, and again in the early hours of May 2 in Tokyo. "This was larger than expected, underscoring Japan's resolve to ease the pain of imported inflation," said Daisaku Ueno, chief FX strategist at Mitsubishi UFJ Morgan Stanley Securities.
Associated Press
Stock market today: Wall Street rallies to close out a bloom-filled May
An already verdant May for Wall Street finished with another push higher as stocks rallied Friday after a report showed inflation is at least not worsening. The main measure of the U.S. stock market’s health set an all-time high late in the month after clawing back all its losses from a rough April. The Dow Jones Industrial Average jumped nearly 575 points, or 1.5%, while sagging prices for some big technology stocks held back the Nasdaq composite.
Barrons.com
Bitcoin Gains. Why the Largest Crypto Will Continue to Dominate Over Ether.
Bitcoin and other cryptocurrencies were mostly rising on Friday. The largest crypto has lost the limelight to Ether this month but that could be short-lived. Bitcoin hit a record high near $74,000 in mid-March amid a surge of interest from new spot exchange-traded funds but its price has dropped since then.
Benzinga
Alibaba and Coupang Intensify E-Commerce Battle with Major Investments in South Korea
Alibaba Group Holding Limited (NYSE:BABA), through its online platform AliExpress, has significantly increased its presence in South Korea, doubling its users to 8.58 million by April, according to Wiseapp. Alibaba earmarked $1.1 billion for South Korea to build a new logistics center. This expansion comes amid fierce competition from domestic e-retailer Coupang, Inc (NYSE:CPNG), which is aggressively investing in advanced technologies and logistics to maintain its market share, taking a cue fro
Reuters
China's factory activity unexpectedly dips as property pain persists
BEIJING (Reuters) -China's manufacturing activity unexpectedly fell in May, keeping alive calls for fresh stimulus as a protracted property crisis in the world's second-largest economy continues to weigh on business, consumer and investor confidence. "I think the data particularly reflects soft domestic demand, the housing sector continued to worsen and retail sales were not strong," said Xu Tianchen, senior economist at the Economist Intelligence Unit.
Zacks
Investors Heavily Search Alibaba Group Holding Limited (BABA): Here is What You Need to Know
Alibaba (BABA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Reuters
Struggling Dow transport stocks could be economic warning signal
It's been a banner year for the major U.S. stock indexes, but one economically sensitive corner of the market sticks out as a sore spot. The Dow Jones Transportation Average has fallen about 5% so far this year, a significant contrast with the 9% year-to-date rise for the benchmark S&P 500 and the 1% rise in the Dow Jones Industrial Average, which topped 40,000 points for the first time this month. While major indexes including the S&P 500, the Nasdaq Composite and the Dow have all set new all-time highs this year, the Dow transports have yet to top their November 2021 record, and are some 12% below that level.
Zacks
RTX Secures a $302M Contract to Support F135 Propulsion Systems
RTX is set to procure long-lead time materials as well as the manufacture, assembly, inspection, acceptance and delivery of 108 conventional takeoff and landing F135 propulsion systems.

Straits Times Index

Nikkei

Hang Seng

FTSE 100

Bitcoin USD

CMC Crypto 200

S&P 500

Dow

Nasdaq

Gold

Crude Oil

10-Yr Bond

FTSE Bursa Malaysia

Jakarta Composite Index

PSE Index

Financial Highlights and Performance Analysis

Strategic Developments and Future Outlook

Corporate Leadership Updates

Conclusion

Latest stories